Sven Zimmermann
Directeur Général chez Inotrem SA
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jean-Jacques Garaud | M | 69 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | 11 ans |
Thierry Hercend | M | - |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
Marc Derive | M | - |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | 11 ans |
Bernard Mach | M | 90 |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | 19 ans |
Luke Beshar | M | 65 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
T. Scott Johnson | M | 76 |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | - |
Thomas Möller | M | 54 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
François Thomas | M | 66 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
Hans Caspar von der Crone | M | 67 |
University of Zurich
| 27 ans |
Graziano Seghezzi | M | 55 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
Gilles Nobécourt | M | 67 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
Ena Prossner | M | 58 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | 4 ans |
Martin Koch | M | 62 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | 6 ans |
Ksenija Aranicki Pavletic | F | - |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | - |
Jason Robert Dinges | M | 48 |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | - |
Clarence Peter | M | - |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Marc Weber | M | 53 |
University of Zurich
| 7 ans |
Reto Suter | M | 53 |
University of Zurich
| 8 ans |
Judith Bischof | M | 50 |
University of Zurich
| 6 ans |
Rene Dittrich | M | 52 |
University of Zurich
| 6 ans |
Cédric Perlet | M | - |
University of Zurich
| 7 ans |
Teodoro D. Cocca | M | 51 |
University of Zurich
| 7 ans |
Marcel Kucher | M | 53 |
University of Zurich
| 4 ans |
Daniel Anders | M | 54 |
University of Zurich
| 2 ans |
Iris Bohnet Zürcher | M | 58 |
University of Zurich
| 3 ans |
Christian Kopfli | M | 58 |
University of Zurich
| 3 ans |
Martin Eisenring | M | - |
University of Zurich
| 3 ans |
Andreas Knecht | M | 55 |
University of Zurich
| 6 ans |
Oliver Hofmann | M | 53 |
University of Zurich
| 4 ans |
André Odermatt | M | 64 |
University of Zurich
| 4 ans |
Nic Dreckmann | M | 50 |
University of Zurich
| 4 ans |
Hans Wicki | M | 60 |
University of Zurich
| 5 ans |
Dimitri Papadopoulos | M | - |
University of Zurich
| 3 ans |
Marija Zecevic | M | 51 |
University of Zurich
| 5 ans |
Sven Schaltegger | M | - |
University of Zurich
| 7 ans |
Morten Holm Pedersen | M | - |
University of Zurich
| 2 ans |
Reto Schnabel | M | - |
University of Zurich
| 4 ans |
Thomas Gottstein | M | 60 |
University of Zurich
| 3 ans |
Rudolf Keller | M | - |
University of Zurich
| 7 ans |
Marco Probst | M | - |
University of Zurich
| 5 ans |
Tobias Foster | M | 49 |
University of Zurich
| 4 ans |
Marcel Dillier | M | - |
University of Zurich
| 5 ans |
Wolfgang Weber | M | 57 |
University of Zurich
| 3 ans |
Patrick Schildknecht | M | 52 |
University of Zurich
| 4 ans |
Michael Steinmann | M | 58 |
University of Zurich
| 3 ans |
Michael Sidler | M | 55 |
University of Zurich
| 3 ans |
Nicole Tschudi | F | 52 |
University of Zurich
| 5 ans |
Michael Altorfer | M | - |
University of Zurich
| 3 ans |
Patrick Frost | M | 56 |
University of Zurich
| 3 ans |
Chris Burger | M | - |
University of Zurich
| 6 ans |
Beat Buehlmann | M | 56 |
University of Zurich
| 3 ans |
Markus Foser | M | 55 |
University of Zurich
| 4 ans |
Patrik Forrer | M | - |
University of Zurich
| 3 ans |
Rahul Sen Gupta | M | 52 |
University of Zurich
| 1 ans |
Peter Lichtlen | M | 56 |
University of Zurich
| 4 ans |
Haleh Brönner | M | 55 |
University of Zurich
| 6 ans |
Marc Loeb | M | 53 |
University of Zurich
| 1 ans |
Giacomo Balzarini | M | 56 |
University of Zurich
| 4 ans |
Philippe Schenk | M | - |
University of Zurich
| 3 ans |
Renata Jungo Brüngger | F | 62 |
University of Zurich
| 2 ans |
Daniel Schmucki | M | 56 |
University of Zurich
| 1 ans |
Thomas Moser | M | 57 |
University of Zurich
| 3 ans |
Patrick Rene Stutz | M | - |
University of Zurich
| 6 ans |
Roger Meier-Rossi | M | - |
University of Zurich
| 3 ans |
Andreas Schulthess | M | 54 |
University of Zurich
| 4 ans |
Beat Walti | M | 55 |
University of Zurich
| 3 ans |
Thomas Oetterli | M | 55 |
University of Zurich
| 4 ans |
Nicola C. Port | F | - |
University of Zurich
| 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Suisse | 57 | 83,82% |
France | 11 | 16,18% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Sven Zimmermann
- Réseau Personnel